Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Matthew B. Klein is recorded as CEO at Ptc Therapeutics, Inc. (PTCT). Ptc Therapeutics, Inc. reported in an 8-K filed March 24, 2023 that Matthew B. Klein was appointed Chief Executive Officer and President and a member of the Board, effective March 22, 2023. Matthew B. Klein has spoken on 2 earnings calls and 1 other investor event across 1 company, most recently for Ptc Therapeutics, Inc. on July 30, 2026.
“On March 22, 2023, the Board of Directors (the "Board") of PTC Therapeutics, Inc. (the "Company") appointed Dr. Matthew B. Klein, age 51, as Chief Executive Officer and President and a member of the Board, effective as of March 22, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2023-03-22–present
Recorded roles and call appearances connecting this person to public companies.
CEO
2023-03-22–present
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
